Clinical Trial Update: BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity [Phase 3]

View source ↗

Summary

Phase 3 open-label trial updating pediatric lower limb spasticity treatment with BOTOX, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Muscle Spasticity

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Pediatrics, Muscle Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2019-08-21